0000000000814734

AUTHOR

Anna Zurlo

showing 2 related works from this author

High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study

2015

Background and aims: Serum uric acid (SUA) is the end-product of purine metabolism in humans, and its levels often increase in subjects with metabolic syndrome (MetS). Despite several studies demonstrating a relationship between increased SUA levels and the prevalence of MetS, prospective data on SUA as a predictor of the incidence of MetS in the elderly are limited. Our aim was to conduct a prospective study on the association between SUA concentrations and the onset of MetS in an elderly Italian cohort. Methods and results: This is a cohort study (Progetto Veneto Anziani Pro.V.A.) involving community-dwelling subjects aged ≥65 years and followed up for a mean 4.4 years. We included 1128 p…

MaleTime FactorsEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030204 cardiovascular system & hematologychemistry.chemical_compoundEndocrinology0302 clinical medicineElderlyLongitudinal StudiesProspective StudiesProspective cohort studyAged 80 and overMetabolic SyndromeCohort study; Community-dwelling adults; Elderly; Metabolic syndrome X; Uric acid; Medicine (miscellaneous); Nutrition and Dietetics; Endocrinology Diabetes and Metabolism; Cardiology and Cardiovascular MedicineNutrition and DieteticsIncidence (epidemiology)IncidenceAge FactorsUp-RegulationDiabetes and MetabolismItalyCohortFemaleCardiology and Cardiovascular MedicineCommunity-dwelling adultCohort studyCohort studymedicine.medical_specialtyNational Health and Nutrition Examination Survey030209 endocrinology & metabolismHyperuricemiaRisk Assessment03 medical and health sciencesSex FactorsMetabolic syndrome XInternal medicinemedicineHumansAgedProportional Hazards Modelsbusiness.industrymedicine.diseaseCommunity-dwelling adultsEndocrinologyLogistic ModelschemistryLinear ModelsUric acidMetabolic syndromebusinessBody mass indexUric acidBiomarkersFollow-Up Studies
researchProduct

Magnesium Status in Alzheimer's Disease: A Systematic Review

2016

The interest in poor magnesium (Mg) status as risk factor for Alzheimer's disease (AD) is increasing due to its antioxidant and neuroprotective properties. A systematic PubMed literature search of studies investigating Mg status was undertaken comparing AD to healthy controls (HCs) or patients with medical illness (medical controls [MCs]). Standardized mean differences (SMDs) ± 95% confidence intervals (CIs) were calculated for all outcomes. Of 192 potentially eligible studies, 13 were included (559 patients with AD, 381 HCs, and 126 MCs). Compared to HCs, patients with AD had significantly lower Mg in cerebrospinal fluid (2 studies; SMD = -0.35; P =.02) and in hair (2 studies; SMD = -0.75;…

0301 basic medicineAlzheimer’s disease; aging; dementia; healthy controls; magnesiummedicine.medical_specialtyDiseasemagnesiumbehavioral disciplines and activitiesnot knownNO03 medical and health sciences0302 clinical medicineAlzheimer DiseaseMedical illnessInternal medicinemedicineHumansDementiaRisk factorbusiness.industryGeneral NeuroscienceagingAlzheimer's diseasemedicine.diseaseConfidence intervalPsychiatry and Mental healthClinical Psychology030104 developmental biologyPhysical therapyhealthy controlsaging; Alzheimer's disease; dementia; healthy controls; magnesium; Psychiatry and Mental Health; Geriatrics and Gerontology; Clinical PsychologyGeriatrics and GerontologyAlzheimer's diseasebusinessAlzheimer’s disease030217 neurology & neurosurgerydementia
researchProduct